| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 3.4e-05 | 1 |